Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study

PHASE3CompletedINTERVENTIONAL
Enrollment

905

Participants

Timeline

Start Date

January 5, 2012

Primary Completion Date

October 14, 2013

Study Completion Date

October 14, 2013

Conditions
Hypercholesterolemia
Interventions
BIOLOGICAL

Evolocumab

Administered by subcutaneous injection once a month

BIOLOGICAL

Placebo

Administered by subcutaneous injection once a month

DRUG

Atorvastatin

Background lipid lowering therapy: 10 mg or 80 mg atorvastatin orally once daily.

DRUG

Ezetimibe

Background lipid lowering therapy: ezetimibe 10 mg orally once a day

OTHER

Diet Only

Diet only, no lipid lowering background drug given

Trial Locations (96)

1085

Research Site, Budapest

1115

Research Site, Budapest

1125

Research Site, Budapest

1200

Research Site, Brussels

2015

Research Site, Camperdown

2035

Research Site, Maroubra

2750

Research Site, Ballerup Municipality

2991

Research Site, Komárom

3065

Research Site, Fitzroy

3945

Research Site, Ham

4064

Research Site, Milton

4092

Research Site, Chatsworth, Durban

4126

Research Site, eManzimtoti

4152

Research Site, Carina Heights

4600

Research Site, Wels

5020

Research Site, Salzburg

5520

Research Site, Anthée

6000

Research Site, Perth

6020

Research Site, Innsbruck

6500

Research Site, Baja

6534

Research Site, Gozée

6720

Research Site, Szeged

6807

Research Site, Feldkirch

7100

Research Site, Vejle

7130

Research Site, Somerset West

7505

Research Site, Parow

7624

Research Site, Pécs

7646

Research Site, Paarl

7925

Research Site, Observatory

8400

Research Site, Ostend

8900

Research Site, Zalaegerszeg

9000

Research Site, Ghent

Research Site, Aalborg

9301

Research Site, Bloemfontein

12553

Research Site, New Windsor

13760

Research Site, Endwell

16635

Research Site, Duncansville

20815

Research Site, Chevy Chase

20817

Research Site, Bethesda

21045

Research Site, Columbia

23294

Research Site, Richmond

27609

Research Site, Raleigh

27612

Research Site, Raleigh

29464

Research Site, Mt. Pleasant

30338

Research Site, Atlanta

30342

Research Site, Atlanta

31406

Research Site, Savannah

32081

Research Site, Ponte Vedra

32204

Research Site, Jacksonville

32216

Research Site, Jacksonville

32720

Research Site, DeLand

35216

Research Site, Birmingham

38654

Research Site, Olive Branch

40213

Research Site, Louisville

44311

Research Site, Akron

45219

Research Site, Cincinnati

45227

Research Site, Cincinnati

45246

Research Site, Cincinnati

46260

Research Site, Indianapolis

55114

Research Site, Saint Paul

57702

Research Site, Rapid City

58103

Research Site, Fargo

60610

Research Site, Chicago

72205

Research Site, Little Rock

73069

Research Site, Norman

77030

Research Site, Houston

89148

Research Site, Las Vegas

91361

Research Site, Westlake Village

91978

Research Site, Spring Valley

92024

Research Site, Encinitas

92801

Research Site, Anaheim

98057

Research Site, Renton

98104

Research Site, Seattle

04210

Research Site, Auburn

02301

Research Site, Brockton

V8T 5G4

Research Site, Victoria

A0A 1G0

Research Site, Bay Roberts

N1R 6V6

Research Site, Cambridge

P3C 5K7

Research Site, Greater Sudbury

N5W 6A2

Research Site, London

L3Y 5G8

Research Site, Newmarket

M9V 4B4

Research Site, Toronto

M9W 4L6

Research Site, Toronto

H9R 3J1

Research Site, Pointe-Claire

G1V 4M6

Research Site, Québec

602 00

Research Site, Brno

625 00

Research Site, Brno

430 02

Research Site, Chomutov

500 05

Research Site, Hradec Králové

530 02

Research Site, Pardubice

305 99

Research Site, Pilsen

120 00

Research Site, Prague

140 21

Research Site, Prague

150 06

Research Site, Prague

274 01

Research Site, Slaný

0140

Research Site, Lyttelton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY